Compound based on CRBN ligand inducing EGFR degradation and preparation method thereof, pharmaceutical composition and application

A compound and composition technology, applied in the field of pharmaceutical compound synthesis, can solve the problems of side effects, reduce the anti-tumor effect of EGFR inhibitors, drug resistance, etc., and achieve the effects of reducing toxic side effects, excellent EGFR protein degradation, and good anti-tumor activity.
CN110372669AActive Publication Date: 2019-10-25ZHEJIANG ACAD OF MEDICAL SCI
5 Cites 11 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
ZHEJIANG ACAD OF MEDICAL SCI
Publication Date
2019-10-25

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a compound based on CRBN ligand inducing EGFR degradation as shown in the following formula I or a pharmacologically acceptable salt and hydrate. The invention further discloses a preparation method of the compound and a pharmaceutical composition of the compound, and application of the compound and the pharmaceutical composition to preparation of drugs for prevention or / and treatment of a cancer. The compound can carry out ubiquitination labeling on the EGFR, protein degradation can be induced with only less dosage, the process is similar to a catalytic reaction, drugswith same molar weight do not need, and the toxic and side effect on a human body can be reduced; and the excellent EGFR protein degradation effect and anticancer activity can be further shown, the anticancer effect of the compound is better than that of an EGFR inhibitor, the compound can be used for preventing or / and treating a variety of cancers, and has a great application prospect in the field of healing drugs.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The present invention relates to the field of pharmaceutical compound synthesis, in particular to a compound based on CRBN ligand-induced EGFR degradation, its preparation method, pharmaceutical composition and application. Background technique

[0002] Cereblon is a protein encoded by the human CRBN gene, and the CRBN homologs are highly conserved, suggesting its importance in physiology. Cereblon forms the E3 ubiquitin ligase complex with damaged DNA-binding protein 1 (DDBl), Cullin-4A (CUL4A) and Cullin-1 regulator (ROCI), which can ubiquitinate a series of proteins, but the specific mechanism is not yet clear. clear. Cereblon ubiquitination of target proteins resulted in an increase in fibroblast growth factor 8 (FGFB) and fibroblast growth factor 10 (FGF10), indicating that the ubiquitinase complex is important for embryonic limb growth.

[0003] Studies have shown that lenalidomide has multiple effects such as anti-tumor, immune regulation and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More